- Home
- EDSA vs MCVT Comparison
EDSA vs MCVT Comparison
Compare EDSA & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- MCVT
- Stock Information
- Founded
- EDSA 2015
- MCVT 2007
- Country
- EDSA Canada
- MCVT United States
- Employees
- EDSA 16
- MCVT N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- MCVT Finance Companies
- Sector
- EDSA Health Care
- MCVT Finance
- Exchange
- EDSA Nasdaq
- MCVT Nasdaq
- Market Cap
- EDSA 14.7M
- MCVT 11.1M
- IPO Year
- EDSA N/A
- MCVT N/A
- Fundamental
- Price
- EDSA $2.39
- MCVT $1.73
- Analyst Decision
- EDSA Strong Buy
- MCVT
- Analyst Count
- EDSA 2
- MCVT 0
- Target Price
- EDSA $13.00
- MCVT N/A
- AVG Volume (30 Days)
- EDSA 30.7K
- MCVT 23.6K
- Earning Date
- EDSA 08-08-2025
- MCVT 08-13-2025
- Dividend Yield
- EDSA N/A
- MCVT N/A
- EPS Growth
- EDSA N/A
- MCVT N/A
- EPS
- EDSA N/A
- MCVT 0.19
- Revenue
- EDSA N/A
- MCVT $3,246,479.00
- Revenue This Year
- EDSA N/A
- MCVT N/A
- Revenue Next Year
- EDSA N/A
- MCVT N/A
- P/E Ratio
- EDSA N/A
- MCVT $9.28
- Revenue Growth
- EDSA N/A
- MCVT N/A
- 52 Week Low
- EDSA $1.55
- MCVT $1.13
- 52 Week High
- EDSA $5.59
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- EDSA 73.15
- MCVT 41.94
- Support Level
- EDSA $1.89
- MCVT $1.78
- Resistance Level
- EDSA $2.23
- MCVT $1.96
- Average True Range (ATR)
- EDSA 0.11
- MCVT 0.07
- MACD
- EDSA 0.04
- MCVT -0.02
- Stochastic Oscillator
- EDSA 81.54
- MCVT 7.77
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.